Frank R. Oakes - 20 Jul 2023 Form 4/A - Amendment Insider Report for Edesa Biotech, Inc. (EDSA)

Role: Director
Signature: /s/ Frank R. Oakes
Issuer symbol: EDSA
Transactions as of: 20 Jul 2023
Net transactions value: $0
Form type: 4/A - Amendment
Filing time: 24 Jul 2023, 16:45:59 UTC
Date Of Original Report: 21 Jul 2023
Previous filing: 07 Mar 2022
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	EDSA	Share Option (right to buy)	Award	$0	+20,000		$0.000000	20,000	20 Jul 2023	Common Shares	20,000	$0.8277	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This option vests monthly in equal proportions over 12 months beginning on the date of grant.

Remarks:

This amendment on Form 4/A is being filed to amend the Form 4 filed on July 21, 2023, solely to correct an administrative error in the expiration date of the Share Option previously reported in Column 6 of Table II.